Through a US$ 29 million grant, South Africa will receive enough medicine to provide HIV prevention to 450 000 people at high ...

South Africa has become the first African country, and our medicines regulator the third worldwide, to register the ...

In these uncertain, volatile, and unprecedented times, the role of science is more important than ever. Scientific advances that benefit humanity and ensure planetary sustainability for current and ...

South Africa has become the first African country – and our medicines regulator the third worldwide – to register the ...

HIV can throw the body clock off balance, leaving many people living with the virus in a constant state of “jet lag,” according to a new study in The Lancet HIV involving Wits University researchers.

One in 10 clinics in South Africa will start to hand out a twice-a-year anti-HIV jab as early as February. The country’s medicines regulator, Sahpra, says it’s on track to announce its registration ...

By William Baloyi When President Donald Trump issued an executive order suspending all foreign aid to South Africa, in ...

It is believed the lenacapavir shot could end HIV/Aids in the country within 14 to 18 years if enough people were to take it.

The drug, Lenacapavir, is the world's first injectable Pre-Exposure Prophylaxis (PrEP). According to the World Health ...

Sleep, often overlooked in routine HIV care, could be the missing vital sign that determines how long and how well people ...

South Africa has become the first African country to register lenacapavir, a groundbreaking six-monthly HIV prevention ...

JOHANNESBURG — Just a week had remained before scientists in South Africa were to begin clinical trials of an HIV vaccine, and hopes were high for another step toward limiting one of history’s ...